Publications

Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.

Ghosh, S; Chan, JM W; Lea, CR; Meints, GA; Lewis, JC; Tovian, ZS; Flessner, RM; Loftus, TC; Bruchhaus, I; Kendrick, H; CROFT, SL; Kemp, RG; Kobayashi, S; Nozaki, T; Oldfield, E;

2003

Journal of medicinal chemistry, (2003).47 1 10.1021/jm030084x.

Screening of plant extracts for antiprotozoal and cytotoxic activities.

Camacho, MD R; Phillipson, JD; CROFT, SL; Solis, PN; Marshall, SJ; Ghazanfar, SA;

2003

Journal of ethnopharmacology, (2003).89 2-3 10.1016/s0378-8741(03)00269-1.

Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the US.

Field, D; NORMAND, C; ELBOURNE, D;

2003

Pediatrics, (2003).112 6 Pt 1 10.1542/peds.112.6.1422.

Classical versus relational approaches to understanding controls on a contract with independent GPs in South Africa.

Palmer, N; MILLS, A;

2003

Health economics, (2003).12 12 10.1002/hec.792.

Sexually transmitted infections in Africa: single dose treatment is now affordable.

Pépin, J; MABEY, D;

2003

Sexually transmitted infections, (2003).79 6 10.1136/sti.79.6.432.

Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa.

Cooke, GS; Aucan, C; Walley, AJ; Segal, S; GREENWOOD, BM; Kwiatkowski, DP; Hill, AV S;

2003

The American journal of tropical medicine and hygiene, (2003).69 6 10.4269/ajtmh.2003.69.565.

Costs of near-miss obstetric complications for women and their families in Benin and Ghana.

BORGHI, J; HANSON, K; Acquah, CA; Ekanmian, G; FILIPPI, V; RONSMANS, C; Brugha, R; Browne, E; Alihonou, E;

2003

Health policy and planning, (2003).18 4 10.1093/heapol/czg046.

Integrated Management of Childhood Illnesses strategy: compliance with referral and follow-up recommendations in Gezira State, Sudan.

Al Fadil, SM; Alrahman, SH A; COUSENS, S; Bustreo, F; Shadoul, A; Farhoud, S; El Hassan, SM;

2003

Bulletin of the World Health Organization, (2003).81 10

Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.

Larabi, M; YARDLEY, V; Loiseau, PM; Appel, M; Legrand, P; Gulik, A; Bories, C; CROFT, SL; Barratt, G;

2003

Antimicrobial agents and chemotherapy, (2003).47 12 10.1128/AAC.47.12.3774-3779.2003.

2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase.

Pez, D; Leal, I; Zuccotto, F; Boussard, C; Brun, R; CROFT, SL; YARDLEY, V; Ruiz Perez, LM; Gonzalez Pacanowska, D; Gilbert, IH;

2003

Bioorganic & medicinal chemistry, (2003).11 22 10.1016/j.bmc.2003.08.012.